BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rajitha B, Belalcazar A, Nagaraju GP, Shaib WL, Snyder JP, Shoji M, Pattnaik S, Alam A, El-rayes BF. Inhibition of NF-κB translocation by curcumin analogs induces G0/G1 arrest and downregulates thymidylate synthase in colorectal cancer. Cancer Letters 2016;373:227-33. [DOI: 10.1016/j.canlet.2016.01.052] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Geng C, Li J, Ding F, Wu G, Yang Q, Sun Y, Zhang Z, Dong T, Tian X. Curcumin suppresses 4-hydroxytamoxifen resistance in breast cancer cells by targeting SLUG/Hexokinase 2 pathway. Biochem Biophys Res Commun 2016;473:147-53. [PMID: 27012210 DOI: 10.1016/j.bbrc.2016.03.067] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
2 Nagaraju GP, Benton L, Bethi SR, Shoji M, El-Rayes BF. Curcumin analogs: Their roles in pancreatic cancer growth and metastasis. Int J Cancer 2019;145:10-9. [PMID: 30226272 DOI: 10.1002/ijc.31867] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
3 Wei Y, Yang P, Cao S, Zhao L. The combination of curcumin and 5-fluorouracil in cancer therapy. Arch Pharm Res 2018;41:1-13. [PMID: 29230689 DOI: 10.1007/s12272-017-0979-x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]
4 Perrone L, Squillaro T, Napolitano F, Terracciano C, Sampaolo S, Melone MAB. The Autophagy Signaling Pathway: A Potential Multifunctional Therapeutic Target of Curcumin in Neurological and Neuromuscular Diseases. Nutrients 2019;11:E1881. [PMID: 31412596 DOI: 10.3390/nu11081881] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
5 Jianxin C, Qingxia X, Junhui W, Qinhong Z. A Case of Recurrent Hepatocellular Carcinoma Acquiring Complete Remission of Target Lesion With Treatment With Traditional Chinese Medicine. Integr Cancer Ther 2017;16:597-604. [PMID: 27444311 DOI: 10.1177/1534735416660617] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
6 Shen H, Shen J, Pan H, Xu L, Sheng H, Liu B, Yao M. Curcumin analog B14 has high bioavailability and enhances the effect of anti-breast cancer cells in vitro and in vivo. Cancer Sci 2021;112:815-27. [PMID: 33316116 DOI: 10.1111/cas.14770] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Zanganeh M, Mazloomi SN, Alijanpour E, Jabbari A; Department of Gynecology and Midwifery, Golestan University of Medical Sciences, Gorgan, Iran, Department of Food Science and Technology, Gorgan University of Agricultural and Natural Sciences, Gorgan, Iran, Department of Anesthesiology and Critical Care Medicine, Babol University of Medical Sciences, Babol, Iran, Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran,5. Department of Anesthesiology and Critical Care Medicine, Golestan University of Medical Sciences, Gorgan, Iran , 6. Clinical Research Development Unit, 5 Azar Hospital, Golestan University of Medical Sciences, Gorgan, Iran. Curcumin and Pregnancy Problems: a Narrative Review of Curcumin's Effect on Preeclampsia. jcbr 2020;4:1-7. [DOI: 10.52547/jcbr.4.4.1] [Reference Citation Analysis]
8 Xu Z, Qu H, Ren Y, Gong Z, Ri HJ, Chen X. An Update on the Potential Roles of E2F Family Members in Colorectal Cancer. Cancer Manag Res 2021;13:5509-21. [PMID: 34276228 DOI: 10.2147/CMAR.S320193] [Reference Citation Analysis]
9 Xu H, Liu L, Li W, Zou D, Yu J, Wang L, Wong CC. Transcription factors in colorectal cancer: molecular mechanism and therapeutic implications. Oncogene 2021;40:1555-69. [PMID: 33323976 DOI: 10.1038/s41388-020-01587-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
10 Zhou J, Miao H, Li X, Hu Y, Sun H, Hou Y. Curcumin inhibits placental inflammation to ameliorate LPS-induced adverse pregnancy outcomes in mice via upregulation of phosphorylated Akt. Inflamm Res 2017;66:177-85. [PMID: 27817102 DOI: 10.1007/s00011-016-1004-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
11 Sultana S, Munir N, Mahmood Z, Riaz M, Akram M, Rebezov M, Kuderinova N, Moldabayeva Z, Shariati MA, Rauf A, Rengasamy KRR. Molecular targets for the management of cancer using Curcuma longa Linn. phytoconstituents: A Review. Biomed Pharmacother 2021;135:111078. [PMID: 33433356 DOI: 10.1016/j.biopha.2020.111078] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
12 Wang Y, Bao X, Zhao A, Zhang J, Zhang M, Zhang Q, Ma B. Raddeanin A inhibits growth and induces apoptosis in human colorectal cancer through downregulating the Wnt/β-catenin and NF-κB signaling pathway. Life Sci 2018;207:532-49. [PMID: 29972765 DOI: 10.1016/j.lfs.2018.06.035] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
13 Wojcik M, Krawczyk M, Wojcik P, Cypryk K, Wozniak LA. Molecular Mechanisms Underlying Curcumin-Mediated Therapeutic Effects in Type 2 Diabetes and Cancer. Oxid Med Cell Longev 2018;2018:9698258. [PMID: 29743988 DOI: 10.1155/2018/9698258] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
14 Ouyang X, Qin F, Huang R, Liang D, Wang C, Wang H, Liao Z. NF-κB inhibitory and cytotoxic activities of hexacyclic triterpene acid constituents from Glechoma longituba. Phytomedicine 2019;63:153037. [DOI: 10.1016/j.phymed.2019.153037] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
15 Li C, Zhao Z, Zhou J, Liu Y, Wang H, Zhao X. Relationship between the TERT, TNIP1 and OBFC1 genetic polymorphisms and susceptibility to colorectal cancer in Chinese Han population. Oncotarget 2017;8:56932-41. [PMID: 28915643 DOI: 10.18632/oncotarget.18378] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
16 Xiao Y, Xu C, Xiong H, Du S, Zhou J, Yin L, Yao J. Dose-reduction antiangiogenic curcumin-low molecular weight heparin nanodrugs for enhanced combinational antitumor therapy. European Journal of Pharmaceutical Sciences 2018;119:121-34. [DOI: 10.1016/j.ejps.2018.04.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
17 Giordano A, Tommonaro G. Curcumin and Cancer. Nutrients 2019;11:E2376. [PMID: 31590362 DOI: 10.3390/nu11102376] [Cited by in Crossref: 120] [Cited by in F6Publishing: 95] [Article Influence: 40.0] [Reference Citation Analysis]
18 Zhao H, Liu Q, Wang S, Dai F, Cheng X, Cheng X, Chen W, Zhang M, Chen D. In vitro additive antitumor effects of dimethoxycurcumin and 5-fluorouracil in colon cancer cells. Cancer Med 2017;6:1698-706. [PMID: 28573788 DOI: 10.1002/cam4.1114] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
19 Danafar H, Salehiabar M, Barsbay M, Rahimi H, Ghaffarlou M, Arbabi Zaboli K, Faghfoori MH, Kaboli S, Nosrati H, Faghfoori Z. Curcumin delivery by modified biosourced carbon-based nanoparticles. Nanomedicine (Lond) 2022;17:95-105. [PMID: 35000461 DOI: 10.2217/nnm-2021-0225] [Reference Citation Analysis]
20 Alam MN, Almoyad M, Huq F. Polyphenols in Colorectal Cancer: Current State of Knowledge including Clinical Trials and Molecular Mechanism of Action. Biomed Res Int. 2018;2018:4154185. [PMID: 29568751 DOI: 10.1155/2018/4154185] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 13.0] [Reference Citation Analysis]
21 He YC, He L, Khoshaba R, Lu FG, Cai C, Zhou FL, Liao DF, Cao D. Curcumin Nicotinate Selectively Induces Cancer Cell Apoptosis and Cycle Arrest through a P53-Mediated Mechanism. Molecules 2019;24:E4179. [PMID: 31752145 DOI: 10.3390/molecules24224179] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
22 Jalili‐nik M, Soltani A, Moussavi S, Ghayour‐mobarhan M, Ferns GA, Hassanian SM, Avan A. Current status and future prospective of Curcumin as a potential therapeutic agent in the treatment of colorectal cancer. J Cell Physiol 2018;233:6337-45. [DOI: 10.1002/jcp.26368] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
23 Soleimani A, Rahmani F, Ferns GA, Ryzhikov M, Avan A, Hassanian SM. Role of the NF-κB signaling pathway in the pathogenesis of colorectal cancer. Gene 2020;726:144132. [PMID: 31669643 DOI: 10.1016/j.gene.2019.144132] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 11.7] [Reference Citation Analysis]
24 Khojaste E, Ahmadizadeh C. Catechin Metabolites along with Curcumin Inhibit Proliferation and Induce Apoptosis in Cervical Cancer Cells by Regulating VEGF Expression In-Vitro. Nutr Cancer 2021;:1-10. [PMID: 34121550 DOI: 10.1080/01635581.2021.1936082] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Adeluola A, Zulfiker AHM, Brazeau D, Amin ARMR. Perspectives for synthetic curcumins in chemoprevention and treatment of cancer: An update with promising analogues. Eur J Pharmacol 2021;906:174266. [PMID: 34146588 DOI: 10.1016/j.ejphar.2021.174266] [Reference Citation Analysis]
26 Morshedi K, Borran S, Ebrahimi MS, Masoud Khooy MJ, Seyedi ZS, Amiri A, Abbasi-Kolli M, Fallah M, Khan H, Sahebkar A, Mirzaei H. Therapeutic effect of curcumin in gastrointestinal cancers: A comprehensive review. Phytother Res 2021. [PMID: 34173992 DOI: 10.1002/ptr.7119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Jo S, Yang H, Lee SR, Heo JH, Lee H, Hong E. Curcumae Radix Decreases Neurodegenerative Markers through Glycolysis Decrease and TCA Cycle Activation. Nutrients 2022;14:1587. [DOI: 10.3390/nu14081587] [Reference Citation Analysis]
28 Zangui M, Atkin SL, Majeed M, Sahebkar A. Current evidence and future perspectives for curcumin and its analogues as promising adjuncts to oxaliplatin: state-of-the-art. Pharmacological Research 2019;141:343-56. [DOI: 10.1016/j.phrs.2019.01.020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
29 Haritha NH, Nawab A, Vijayakurup V, Anto NP, Liju VB, Alex VV, Amrutha AN, Aiswarya SU, Swetha M, Vinod BS, Sundaram S, Guijarro MV, Herlevich T, Krishna A, Nestory NK, Bava SV, Sadasivan C, Zajac-Kaye M, Anto RJ. Targeting Thymidylate Synthase Enhances the Chemosensitivity of Triple-Negative Breast Cancer Towards 5-FU-Based Combinatorial Therapy. Front Oncol 2021;11:656804. [PMID: 34336653 DOI: 10.3389/fonc.2021.656804] [Reference Citation Analysis]
30 Nagaraju GP, Farran B, Farren M, Chalikonda G, Wu C, Lesinski GB, El-Rayes BF. Napabucasin (BBI 608), a potent chemoradiosensitizer in rectal cancer. Cancer 2020;126:3360-71. [PMID: 32383803 DOI: 10.1002/cncr.32954] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
31 Dabaghi M, Quaas R, Hilger I. The Treatment of Heterotopic Human Colon Xenograft Tumors in Mice with 5-Fluorouracil Attached to Magnetic Nanoparticles in Combination with Magnetic Hyperthermia Is More Efficient than Either Therapy Alone. Cancers (Basel) 2020;12:E2562. [PMID: 32916798 DOI: 10.3390/cancers12092562] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 Feng T, Wei Y, Lee RJ, Zhao L. Liposomal curcumin and its application in cancer. Int J Nanomedicine 2017;12:6027-44. [PMID: 28860764 DOI: 10.2147/IJN.S132434] [Cited by in Crossref: 108] [Cited by in F6Publishing: 57] [Article Influence: 21.6] [Reference Citation Analysis]
33 Huang YF, Zhu DJ, Chen XW, Chen QK, Luo ZT, Liu CC, Wang GX, Zhang WJ, Liao NZ. Curcumin enhances the effects of irinotecan on colorectal cancer cells through the generation of reactive oxygen species and activation of the endoplasmic reticulum stress pathway. Oncotarget 2017;8:40264-75. [PMID: 28402965 DOI: 10.18632/oncotarget.16828] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]
34 Hussain T, Tan B, Liu G, Murtaza G, Rahu N, Saleem M, Yin Y. Modulatory Mechanism of Polyphenols and Nrf2 Signaling Pathway in LPS Challenged Pregnancy Disorders. Oxid Med Cell Longev 2017;2017:8254289. [PMID: 29138679 DOI: 10.1155/2017/8254289] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
35 Pakizehkar S, Ranji N, Sohi AN, Sadeghizadeh M. Polymersome‐assisted delivery of curcumin: A suitable approach to decrease cancer stemness markers and regulate miRNAs expression in HT29 colorectal cancer cells. Polym Adv Technol 2019;31:160-77. [DOI: 10.1002/pat.4759] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Vemuri SK, Banala RR, Mukherjee S, Uppula P, Gpv S, A.v. GR, T. M. Novel biosynthesized gold nanoparticles as anti-cancer agents against breast cancer: Synthesis, biological evaluation, molecular modelling studies. Materials Science and Engineering: C 2019;99:417-29. [DOI: 10.1016/j.msec.2019.01.123] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 10.7] [Reference Citation Analysis]
37 Naji M, Soroudi S, Akaberi M, Sahebkar A, Emami SA. Updated Review on the Role of Curcumin in Gastrointestinal Cancers. Adv Exp Med Biol 2021;1308:55-89. [PMID: 33861437 DOI: 10.1007/978-3-030-64872-5_6] [Reference Citation Analysis]
38 Martinez-Castillo M, Bonilla-Moreno R, Aleman-Lazarini L, Meraz-Rios MA, Orozco L, Cedillo-Barron L, Cordova EJ, Villegas-Sepulveda N. A Subpopulation of the K562 Cells Are Killed by Curcumin Treatment after G2/M Arrest and Mitotic Catastrophe. PLoS One 2016;11:e0165971. [PMID: 27832139 DOI: 10.1371/journal.pone.0165971] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
39 Assani I, Du Y, Wang CG, Chen L, Hou PL, Zhao SF, Feng Y, Liu LF, Sun B, Li Y, Liao ZX, Huang RZ. Anti-proliferative effects of diterpenoids from Sagittaria trifolia L. tubers on colon cancer cells by targeting the NF-κB pathway. Food Funct 2020;11:7717-26. [PMID: 32789317 DOI: 10.1039/d0fo00228c] [Reference Citation Analysis]
40 Kumari M, Ray L, Purohit MP, Patnaik S, Pant AB, Shukla Y, Kumar P, Gupta KC. Curcumin loading potentiates the chemotherapeutic efficacy of selenium nanoparticles in HCT116 cells and Ehrlich's ascites carcinoma bearing mice. Eur J Pharm Biopharm 2017;117:346-62. [PMID: 28499854 DOI: 10.1016/j.ejpb.2017.05.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 6.2] [Reference Citation Analysis]
41 Mapoung S, Suzuki S, Fuji S, Naiki-Ito A, Kato H, Yodkeeree S, Ovatlarnporn C, Takahashi S, Limtrakul Dejkriengkraikul P. Cyclohexanone curcumin analogs inhibit the progression of castration-resistant prostate cancer in vitro and in vivo. Cancer Sci 2019;110:596-607. [PMID: 30499149 DOI: 10.1111/cas.13897] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
42 Briata IM, Paleari L, Rutigliani M, Petrera M, Caviglia S, Romagnoli P, Libera MD, Oppezzi M, Puntoni M, Siri G, Lazzeroni M, Howells L, Singh R, Brown K, DeCensi A. A Presurgical Study of Curcumin Combined with Anthocyanin Supplements in Patients with Colorectal Adenomatous Polyps. Int J Mol Sci 2021;22:11024. [PMID: 34681684 DOI: 10.3390/ijms222011024] [Reference Citation Analysis]
43 Ruiz de Porras V, Layos L, Martínez-Balibrea E. Curcumin: A therapeutic strategy for colorectal cancer? Semin Cancer Biol 2021;73:321-30. [PMID: 32942023 DOI: 10.1016/j.semcancer.2020.09.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
44 Chainoglou E, Hadjipavlou-litina D. Curcumin analogues and derivatives with anti-proliferative and anti-inflammatory activity: Structural characteristics and molecular targets. Expert Opinion on Drug Discovery 2019;14:821-42. [DOI: 10.1080/17460441.2019.1614560] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
45 Leem DG, Shin JS, Kim KT, Choi SY, Lee MH, Lee KT. Dammarane-type triterpene ginsenoside-Rg18 inhibits human non-small cell lung cancer A549 cell proliferation via G1 phase arrest. Oncol Lett 2018;15:6043-9. [PMID: 29556318 DOI: 10.3892/ol.2018.8057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]